These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 780003)

  • 41. Lack of specificity of the immunoelectroadsorption test with Schistosoma mansoni antigens and a conjugated hapten.
    Williams JS; Stechschulte DJ; Sadun EH
    Am J Trop Med Hyg; 1968 Jul; 17(4):568-75. PubMed ID: 5672786
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules.
    Kobayashi N; Oyama H
    Analyst; 2011 Feb; 136(4):642-51. PubMed ID: 21152564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoassays.
    Kohl TO; Ascoli CA
    Cold Spring Harb Protoc; 2017 Jul; 2017(7):pdb.top093690. PubMed ID: 28679720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two different approaches for developing immunometric assays of haptens.
    Grassi J; Créminon C; Frobert Y; Etienne E; Ezan E; Volland H; Pradelles P
    Clin Chem; 1996 Sep; 42(9):1532-6. PubMed ID: 8787725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of the antibody purification method on immunoassay performance: hapten-antibody binding in accordance with the structure of the affinity column ligand.
    Choi J; Kim C; Choi MJ
    Anal Biochem; 1999 Oct; 274(1):118-24. PubMed ID: 10527504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Principle and applications of ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for antibodies in body fluids.
    Ishikawa E; Hashida S; Kohno T; Hirota K; Hashinaka K; Ishikawa S
    J Clin Lab Anal; 1993; 7(6):376-93. PubMed ID: 8277361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Harnessing the red cell for immunoassays.
    Coombs RR
    Med Lab Sci; 1987 Jan; 44(1):66-72. PubMed ID: 3309534
    [No Abstract]   [Full Text] [Related]  

  • 48. Fluxapyroxad Haptens and Antibodies for Highly Sensitive Immunoanalysis of Food Samples.
    Mercader JV; Abad-Somovilla A; Agulló C; Abad-Fuentes A
    J Agric Food Chem; 2017 Oct; 65(42):9333-9341. PubMed ID: 28974098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristics.
    Pelizzola D; Bombardieri E; Brocchi A; Cappelli G; Coli A; Federghini M; Giganti M; Gion M; Madeddu G; Maussieri ML
    Q J Nucl Med; 1995 Dec; 39(4):251-63. PubMed ID: 8624786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunometric assay of low molecular weight haptens containing primary amino groups.
    Pradelles P; Grassi J; Créminon C; Boutten B; Mamas S
    Anal Chem; 1994 Jan; 66(1):16-22. PubMed ID: 8116875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An affinity-amplified immunoassay for juvenile hormone esterase.
    Székács A; Gee SJ; Jung F; McCutchen BF; Hammock BD
    Anal Biochem; 1992 Dec; 207(2):291-7. PubMed ID: 1481984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive enzyme-liked immunoassay with use of soluble enzyme/antibody immune complexes for labeling. I. Measurement of human choriogonadotropin.
    Yorde DE; Sasse EA; Wang TY; Hussa RO; Garancis JC
    Clin Chem; 1976 Aug; 22(8):1372-7. PubMed ID: 949847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An enzyme-immunoassay of antibody specific for adenosine using beta-galactosidase.
    Lauer RC; Erlanger BF
    Immunochemistry; 1974 Sep; 11(9):533-6. PubMed ID: 4459261
    [No Abstract]   [Full Text] [Related]  

  • 54. Sensitive titration of antibodies and antigens using erythro-immunoassay.
    Guesdon JL; Avrameas S
    Ann Immunol (Paris); 1980; 131C(3):389-96. PubMed ID: 7406443
    [No Abstract]   [Full Text] [Related]  

  • 55. Development and clinical application of sensitive enzyme immunoassay for macromolecular antigens--a review.
    Ishikawa E
    Clin Biochem; 1987 Dec; 20(6):375-85. PubMed ID: 3325191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress and future outlook of enzyme immunoassay].
    Ishikawa E
    Rinsho Byori; 1983 Apr; 31(4):367-71. PubMed ID: 6352993
    [No Abstract]   [Full Text] [Related]  

  • 57. The influence of heterologous combinations of antiserum and enzyme-labeled estrogen on the characteristics of estrogen enzyme-immunoassays.
    van Weeman BK; Schuurs AH
    Immunochemistry; 1975 Aug; 12(8):667-70. PubMed ID: 173650
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular aspects of design of immunoassays for drugs.
    Newman DJ; Price CP
    Ther Drug Monit; 1996 Aug; 18(4):493-7. PubMed ID: 8857574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemiluminescence: applications for the clinical laboratory.
    Boeckx RL
    Hum Pathol; 1984 Feb; 15(2):104-11. PubMed ID: 6321319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studies.
    Schwickart M; Vainshtein I; Lee R; Schneider A; Liang M
    Bioanalysis; 2014; 6(14):1939-51. PubMed ID: 24806787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.